Hepatitis C Drug Trials Halted After Death - Beckley, Bluefield & Lewisburg News, Weather, Sports

Hepatitis C Drug Trials Halted After Death

Posted: Updated:

The Swiss pharmaceutical company Novartis AG says it has halted clinical trials for its hepatitis C drug, Alisporivir, following the death of a patient.

Novartis A-G also informed the US Food and Drug Administration of "a small number" of reported cases of pancreatitis, an inflammation of the pancreas.